117th Congress
Sponsor: Sen. Amy Klobuchar — D — MN
Makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug. The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a law...
Don't be sad- we've got your back. Just enter your email below and instructions on resetting your password will be sent to you.
×